CLAIRE HERKE: Open Payments
NPI 1811778996 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,699 in 109 payments from 16 companies in 2025. Trend: 2023 $153 · 2024 $858 · 2025 $2,699
Food & beverage: $2,622Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $900 |
| Janssen Biotech, Inc. | 22 | $546 |
| GENZYME CORPORATION | 7 | $204 |
| Novo Nordisk Inc | 4 | $182 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $180 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Janssen Scientific Affairs, LLC | 3 | $91 |
| Lilly USA, LLC | 4 | $77 |
| Intercept Pharmaceuticals, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
Products named: TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, Wegovy, XIFAXAN, LINZESS, REZDIFFRA.
Industry payments across LA — which companies pay providers there.
